Keurig Dr Pepper (NASDAQ:KDP) Exceeds Q4 CY2025 Expectations

Beverage company Keurig Dr Pepper (NASDAQ:KDP) announced better-than-expected revenue in Q4 CY2025, with sales up 10.5% year on year to $4.50 billion. Its non-GAAP profit of $0.60 per share was 1.9% above analysts’ consensus estimates.

Is now the time to buy Keurig Dr Pepper? Find out by accessing our full research report, it’s free.

Commenting on the Company's results, CEO Tim Cofer stated, "2025 was another strong year for KDP. We delivered on our guidance, navigated the dynamic operating environment with agility, and executed well in the marketplace with winning innovation and robust commercial activation of our brands. In 2026, we intend to build upon our momentum with the acquisition and integration of JDE Peet's and progress towards the subsequent separation into two advantaged pure play companies."

Company Overview

Born out of a 2018 merger between Keurig Green Mountain and Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ:KDP) is a consumer staples powerhouse boasting a portfolio of beverages including sodas, coffees, and juices.

Revenue Growth

A company’s long-term performance is an indicator of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years.

With $16.6 billion in revenue over the past 12 months, Keurig Dr Pepper is larger than most consumer staples companies and benefits from economies of scale, enabling it to gain more leverage on its fixed costs than smaller competitors. Its size also gives it negotiating leverage with distributors, allowing its products to reach more shelves. However, its scale is a double-edged sword because there are only a finite number of major retail partners, placing a ceiling on its growth. For Keurig Dr Pepper to boost its sales, it likely needs to adjust its prices, launch new offerings, or lean into foreign markets.

As you can see below, Keurig Dr Pepper grew its sales at a mediocre 5.7% compounded annual growth rate over the last three years, but to its credit, consumers bought more of its products.

This quarter, Keurig Dr Pepper reported year-on-year revenue growth of 10.5%, and its $4.50 billion of revenue exceeded Wall Street’s estimates by 3.1%.

Looking ahead, sell-side analysts expect revenue to grow 4.6% over the next 12 months, similar to its three-year rate. This projection doesn't excite us and indicates its products will face some demand challenges.

The 1999 book Gorilla Game predicted Microsoft and Apple would dominate tech before it happened. Its thesis? Identify the platform winners early. Today, enterprise software companies embedding generative AI are becoming the new gorillas. a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Volume Growth

Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.

Keurig Dr Pepper’s average quarterly volume growth was a robust 4.4% over the last two years. This is good because meaningful volume growth is hard to come by in the stable consumer staples sector.

In Keurig Dr Pepper’s Q4 2025, sales volumes jumped 4.8% year on year. This result was in line with its historical levels.

Key Takeaways from Keurig Dr Pepper’s Q4 Results

We enjoyed seeing Keurig Dr Pepper beat analysts’ revenue and EPS expectations this quarter. Overall, this print had some key positives. The stock traded up 2% to $30.25 immediately following the results.

Keurig Dr Pepper put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).